Get the Stockscreener App
14.51
0.34%
-0.04
Bausch Lomb Corp stock is traded at $14.51, with a volume of 7,339.
It is down -0.34% in the last 24 hours and up +4.32% over the past month.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
See More
Previous Close:
$14.55
Open:
$14.54
24h Volume:
7,339
Relative Volume:
0.01
Market Cap:
$5.13B
Revenue:
$4.79B
Net Income/Loss:
$-317.00M
P/E Ratio:
-15.95
EPS:
-0.91
Net Cash Flow:
$-59.00M
1W Performance:
+6.38%
1M Performance:
+4.32%
6M Performance:
-11.31%
1Y Performance:
-9.38%
1-Day Range:
$14.45
$14.54
1-Week Range:
$13.61
$14.86
52-Week Range:
$10.45
$21.69
Bausch Lomb Corp Stock (BLCO) Company Profile
Name
Bausch Lomb Corp
Sector
Industry
Phone
908-541-5456
Address
520 APPLEWOOD CRESCENT, VAUGHAN
Compare BLCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
14.50 | 5.15B | 4.79B | -317.00M | -59.00M | -0.91 |
|
ISRG
Intuitive Surgical Inc
|
481.96 | 172.16B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
196.04 | 56.16B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
88.17 | 43.38B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
284.42 | 41.71B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
243.78 | 17.70B | 2.90B | 467.20M | 306.90M | 6.37 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-02-25 | Reiterated | H.C. Wainwright | Buy |
| Mar-28-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-15-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-10-24 | Initiated | Raymond James | Outperform |
| May-06-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-12-23 | Initiated | Stifel | Hold |
| Oct-03-23 | Resumed | Evercore ISI | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-09-23 | Initiated | Needham | Hold |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Sep-12-22 | Initiated | H.C. Wainwright | Buy |
| Jul-26-22 | Initiated | RBC Capital Mkts | Outperform |
| Jun-24-22 | Initiated | Evercore ISI | Outperform |
| Jun-06-22 | Initiated | Citigroup | Buy |
| May-31-22 | Initiated | Deutsche Bank | Hold |
| May-31-22 | Initiated | Goldman | Neutral |
| May-31-22 | Initiated | Guggenheim | Buy |
| May-31-22 | Initiated | JP Morgan | Neutral |
| May-31-22 | Initiated | Jefferies | Buy |
| May-31-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-31-22 | Initiated | Wells Fargo | Overweight |
| May-11-22 | Initiated | Cowen | Outperform |
View All
Bausch Lomb Corp Stock (BLCO) Latest News
Is it time to cut losses on Bausch + Lomb CorporationJuly 2025 Sector Moves & Verified Short-Term Plans - Newser
How to build a custom watchlist for Bausch + Lomb CorporationJuly 2025 Patterns & Community Consensus Trade Alerts - Newser
What machine learning models say about Bausch + Lomb CorporationProduct Launch & Reliable Price Action Trade Plans - Newser
Is now a turning point for Bausch + Lomb CorporationMarket Activity Report & Real-Time Stock Price Movement Reports - Newser
How hedge fund analytics apply to Bausch + Lomb Corporation stockWeekly Volume Report & Daily Price Action Insights - Newser
Stable Stocks to Watch: Hudson Technologies and Bausch + Lomb Underperform, Intuit Shines - AInvest
Eye Care Leader Bausch + Lomb Leadership to Share Strategic Updates at JPM and Morgan Stanley Events - Stock Titan
Bausch + Lomb to Participate in Upcoming Investor Conferences - Yahoo Finance
Bausch + Lomb’s SWOT analysis: ophthalmology leader faces spin-off uncertainty - Investing.com
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know - Yahoo Finance
How Bausch + Lomb Corporation stock performs during market volatilityLow Float Big Mover Alerts - thegnnews.com
TR | OpenAI4o Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $14 - 富途牛牛
BofA Securities Maintains Bausch + Lomb Corp.(BLCO.US) With Sell Rating, Raises Target Price to $13 - 富途牛牛
Analysts' Opinions on Bausch + Lomb Corporation, Avantor, and AptarGroup: A Mixed Bag - AInvest
Bausch + Lomb (NYSE:BLCO) Price Target Raised to $13.00 - Defense World
Is it the right time to buy Bausch + Lomb Corporation stockMaximize gains with proven stock analysis - Jammu Links News
Bausch + Lomb Corporation (NYSE:BLCO) Q2 2025 Earnings Call Transcript - Insider Monkey
Bausch + Lomb Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Bausch & Lomb Raises Price Target to $16.00 Amid Positive Analyst Sentiment. - AInvest
H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛
Bausch + Lomb:HC Wainwright Raises PT to $16, Maintains Buy Rating - AInvest
Bausch & Lomb Corp (BLCO) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Challenges By GuruFocus - Investing.com Canada
Bausch + Lomb Prices Upsizes and Prices a 675-Million Euro Senior Secured Notes Offering - 富途牛牛
Bausch & Lomb Corp SEC 10-Q Report - TradingView
Bausch + Lomb Q2 Adjusted Income Lower, Revenue Increases - 富途牛牛
Earnings call transcript: Bausch + Lomb Q2 2025 beats earnings expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Bausch + Lomb Q2 2025 beats earnings expectations - Investing.com
Bausch + Lomb Lifts Outlook After Beating Revenue Expectations - Finimize
Bausch + Lomb Corporation - Baystreet.ca
Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Bausch + Lomb Announces Second-Quarter 2025 Results - BioSpace
Bausch + Lomb (BLCO) Q2 Earnings and Revenues Surpass Estimates - ca.finance.yahoo.com
Bausch + Lomb: Q2 Earnings Snapshot - San Antonio Express-News
Bausch + Lomb’s (NYSE:BLCO) Q2 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Bausch + Lomb Q2 2025 slides: Revenue growth accelerates, guidance raised - Investing.com Australia
Bausch + Lomb Q2 2025 slides: Revenue growth accelerates, guidance raised By Investing.com - Investing.com South Africa
Bausch + Lomb tops Q2 expectations, raises full-year guidance By Investing.com - Investing.com Canada
Bausch + Lomb tops Q2 expectations, raises full-year guidance - Investing.com
Bausch + Lomb Q2 2025 Financial Results - TradingView
Examining the Future: Bausch & Lomb's Earnings Outlook - 富途牛牛
Bausch + Lomb Corporation Breaks Below Key Support LevelLow Volatility Stable Growth Picks Rank High - beatles.ru
Stocks In Play: Bausch + Lomb Corporation - Barchart.com
Bausch & Lomb Corp (TSX:BLCO) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops - Stock Titan
Bausch + Lomb Corp expected to post earnings of 7 cents a shareEarnings Preview - TradingView
Bausch + Lomb (BLCO) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
What are analysts’ price targets for Bausch + Lomb Corporation in the next 12 monthsIdentify breakout stocks before they peak - Jammu Links News
Bausch + Lomb Maintained at Outperform at RBC Ahead of Q2 Results; Price Target Kept at US$17.00 - 富途牛牛
What analysts say about Bausch + Lomb Corporation stockFree Trend-Following Techniques - Autocar Professional
Earnings Preview: BLCO to Report Financial Results Pre-market on July 30 - 富途牛牛
Bausch & Lomb amends CEO contract and performance stock unit terms By Investing.com - Investing.com South Africa
Bausch Lomb Corp Stock (BLCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):